ペニシリンの世界市場2023~2027

◆英語タイトル:Global Penicillin Market 2023-2027

Technavioが発行した調査報告書(IRTNTR40093-23)◆商品コード:IRTNTR40093-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年8月
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ペニシリンの世界市場 2023-2027
ペニシリン市場は2022年から2027年にかけて2億4,502万米ドル成長し、予測期間中のCAGRは4.98%で加速すると予測されます。当レポートでは、ペニシリン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引するのは、感染症の流行、様々な疾患とその治療に対する意識の高まり、特別な規制指定などです。

Technavio社のペニシリン市場は以下のように分類されています:

タイプ別
- 経口剤
- 非経口剤

供給源別
- 半合成
- 天然

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、今後数年間におけるペニシリン市場の成長を促進する主な理由の一つとして、戦略的提携とM&Aを挙げています。また、抗生物質研究のための連邦政府および機関への資金提供の増加、輸血を介した感染拡大のリスクの増大は、市場の大きな需要につながるでしょう。

ペニシリン市場に関するレポートは以下の分野をカバーしています:
- ペニシリン市場の規模
- ペニシリン市場予測
- ペニシリン市場分析

本レポートでは、ペニシリン市場の主要ベンダーであるAbbott Laboratories, AdvaCare Pharma, Aenova Holding GmbH, Astellas Pharma Inc., Canvax Biotech SL, Cipla Ltd., F. Hoffmann La Roche Ltd., FUJIFILM Corp., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Lupin Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Recipharm AB, Sanofi, Sun Pharmaceutical Industries Ltd., Viatris Inc., and Wellona Pharma.などを分析しています。また、ペニシリン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。

当レポートは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 タイプ別市場分析
7 ソース別市場分析
8 顧客状況
9 地域別状況
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Source
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global penicillin market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global penicillin market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Source Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Source Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Oral – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 6.4 Parenteral – Market size and forecast 2022-2027
o Exhibit 38: Chart on Parenteral – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Parenteral – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Parenteral – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Parenteral – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Source
o 7.1 Market segments
o Exhibit 44: Chart on Source – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Source – Market share 2022-2027 (%)
o 7.2 Comparison by Source
o Exhibit 46: Chart on Comparison by Source
o Exhibit 47: Data Table on Comparison by Source
o 7.3 Semisynthetic – Market size and forecast 2022-2027
o Exhibit 48: Chart on Semisynthetic – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Semisynthetic – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Semisynthetic – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Semisynthetic – Year-over-year growth 2022-2027 (%)
o 7.4 Natural – Market size and forecast 2022-2027
o Exhibit 52: Chart on Natural – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Natural – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Natural – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Natural – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Source
o Exhibit 56: Market opportunity by Source ($ million)
o Exhibit 57: Data Table on Market opportunity by Source ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 83: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 87: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 12.4 AdvaCare Pharma
o Exhibit 112: AdvaCare Pharma – Overview
o Exhibit 113: AdvaCare Pharma – Product / Service
o Exhibit 114: AdvaCare Pharma – Key offerings
o 12.5 Aenova Holding GmbH
o Exhibit 115: Aenova Holding GmbH – Overview
o Exhibit 116: Aenova Holding GmbH – Product / Service
o Exhibit 117: Aenova Holding GmbH – Key offerings
o 12.6 Canvax Biotech SL
o Exhibit 118: Canvax Biotech SL – Overview
o Exhibit 119: Canvax Biotech SL – Product / Service
o Exhibit 120: Canvax Biotech SL – Key offerings
o 12.7 Cipla Ltd.
o Exhibit 121: Cipla Ltd. – Overview
o Exhibit 122: Cipla Ltd. – Business segments
o Exhibit 123: Cipla Ltd. – Key news
o Exhibit 124: Cipla Ltd. – Key offerings
o Exhibit 125: Cipla Ltd. – Segment focus
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 126: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 127: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 128: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 129: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 130: F. Hoffmann La Roche Ltd. – Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 131: GlaxoSmithKline Plc – Overview
o Exhibit 132: GlaxoSmithKline Plc – Business segments
o Exhibit 133: GlaxoSmithKline Plc – Key news
o Exhibit 134: GlaxoSmithKline Plc – Key offerings
o Exhibit 135: GlaxoSmithKline Plc – Segment focus
o 12.10 Glenmark Pharmaceuticals Ltd.
o Exhibit 136: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 137: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 138: Glenmark Pharmaceuticals Ltd. – Key offerings
o 12.11 Lupin Ltd.
o Exhibit 139: Lupin Ltd. – Overview
o Exhibit 140: Lupin Ltd. – Product / Service
o Exhibit 141: Lupin Ltd. – Key news
o Exhibit 142: Lupin Ltd. – Key offerings
o 12.12 Novartis AG
o Exhibit 143: Novartis AG – Overview
o Exhibit 144: Novartis AG – Business segments
o Exhibit 145: Novartis AG – Key offerings
o Exhibit 146: Novartis AG – Segment focus
o 12.13 Pfizer Inc.
o Exhibit 147: Pfizer Inc. – Overview
o Exhibit 148: Pfizer Inc. – Product / Service
o Exhibit 149: Pfizer Inc. – Key news
o Exhibit 150: Pfizer Inc. – Key offerings
o 12.14 Recipharm AB
o Exhibit 151: Recipharm AB – Overview
o Exhibit 152: Recipharm AB – Business segments
o Exhibit 153: Recipharm AB – Key offerings
o Exhibit 154: Recipharm AB – Segment focus
o 12.15 Sanofi
o Exhibit 155: Sanofi – Overview
o Exhibit 156: Sanofi – Business segments
o Exhibit 157: Sanofi – Key news
o Exhibit 158: Sanofi – Key offerings
o Exhibit 159: Sanofi – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 160: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. – Overview
o Exhibit 164: Viatris Inc. – Business segments
o Exhibit 165: Viatris Inc. – Key news
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Source
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global penicillin market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Source Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Parenteral – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Parenteral – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Parenteral – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Parenteral – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Source – Market share 2022-2027 (%)
Exhibits45: Data Table on Source – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Source
Exhibits47: Data Table on Comparison by Source
Exhibits48: Chart on Semisynthetic – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Semisynthetic – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Semisynthetic – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Semisynthetic – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Natural – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Natural – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Natural – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Natural – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Source ($ million)
Exhibits57: Data Table on Market opportunity by Source ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: AdvaCare Pharma – Overview
Exhibits113: AdvaCare Pharma – Product / Service
Exhibits114: AdvaCare Pharma – Key offerings
Exhibits115: Aenova Holding GmbH – Overview
Exhibits116: Aenova Holding GmbH – Product / Service
Exhibits117: Aenova Holding GmbH – Key offerings
Exhibits118: Canvax Biotech SL – Overview
Exhibits119: Canvax Biotech SL – Product / Service
Exhibits120: Canvax Biotech SL – Key offerings
Exhibits121: Cipla Ltd. – Overview
Exhibits122: Cipla Ltd. – Business segments
Exhibits123: Cipla Ltd. – Key news
Exhibits124: Cipla Ltd. – Key offerings
Exhibits125: Cipla Ltd. – Segment focus
Exhibits126: F. Hoffmann La Roche Ltd. – Overview
Exhibits127: F. Hoffmann La Roche Ltd. – Business segments
Exhibits128: F. Hoffmann La Roche Ltd. – Key news
Exhibits129: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits130: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits131: GlaxoSmithKline Plc – Overview
Exhibits132: GlaxoSmithKline Plc – Business segments
Exhibits133: GlaxoSmithKline Plc – Key news
Exhibits134: GlaxoSmithKline Plc – Key offerings
Exhibits135: GlaxoSmithKline Plc – Segment focus
Exhibits136: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits137: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits138: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits139: Lupin Ltd. – Overview
Exhibits140: Lupin Ltd. – Product / Service
Exhibits141: Lupin Ltd. – Key news
Exhibits142: Lupin Ltd. – Key offerings
Exhibits143: Novartis AG – Overview
Exhibits144: Novartis AG – Business segments
Exhibits145: Novartis AG – Key offerings
Exhibits146: Novartis AG – Segment focus
Exhibits147: Pfizer Inc. – Overview
Exhibits148: Pfizer Inc. – Product / Service
Exhibits149: Pfizer Inc. – Key news
Exhibits150: Pfizer Inc. – Key offerings
Exhibits151: Recipharm AB – Overview
Exhibits152: Recipharm AB – Business segments
Exhibits153: Recipharm AB – Key offerings
Exhibits154: Recipharm AB – Segment focus
Exhibits155: Sanofi – Overview
Exhibits156: Sanofi – Business segments
Exhibits157: Sanofi – Key news
Exhibits158: Sanofi – Key offerings
Exhibits159: Sanofi – Segment focus
Exhibits160: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits161: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits162: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits163: Viatris Inc. – Overview
Exhibits164: Viatris Inc. – Business segments
Exhibits165: Viatris Inc. – Key news
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ペニシリンの世界市場2023~2027(Global Penicillin Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆